Since patients with fatty liver are more likely to develop bacterial infections or sepsis [93], limiting overexpression of CXCL10 could be protective against worsening liver disease, bacterial infection, and even sepsis, although this might require long-term prophylaxis rather than short-term treatment of acute disease. Here, CXCL10 is linked to liver disorder.